{"product_id":"drug-development-in-psychiatry-9783031210563","title":"Drug Development in Psychiatry","description":"\u003cp\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e: Paperback \/ softback\u003cbr\u003e\u003cstrong\u003eLength\u003c\/strong\u003e: 459 pages\u003cbr\u003e\u003cstrong\u003ePublication date\u003c\/strong\u003e: 17 March 2024\u003cbr\u003e\u003cstrong\u003ePublisher\u003c\/strong\u003e: Springer International Publishing AG\u003cbr\u003e\u003c\/p\u003e\u003cp\u003eNovel drugs and disease targets have changed the way developers and regulatory agencies think about clinical trial methodology.The book elucidates how biomarkers, genetics and advances in neuroscience and neuroimaging have influenced drug development approaches, which will ultimately change the practice of psychiatry.\u003c\/p\u003e\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eDimension\u003c\/strong\u003e: 235 x 155 (mm)\u003cbr\u003e\u003cstrong\u003eISBN-13\u003c\/strong\u003e: 9783031210563\u003cbr\u003e \u003cstrong\u003eEdition number\u003c\/strong\u003e: 2023 ed.\u003c\/p\u003e","brand":"Shulph Ink","offers":[{"title":"Paperback \/ softback","offer_id":47425260716282,"sku":"9783031210563","price":166.59,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/4297\/2845\/files\/1750461527596_book_9ca27513-3613-4931-ad5d-a422e979d0b8.jpg?v=1750517337","url":"https:\/\/shulphink.com\/products\/drug-development-in-psychiatry-9783031210563","provider":"Shulph Ink","version":"1.0","type":"link"}